According to MarketsandMarkets™, the Cancer Diagnostics Market is projected to reach USD 44.92 billion by 2031 from USD 29.86 billion in ...

There was a noticeable uptick in digital pathology devices and software clearances among more than a dozen 510(k)s granted by the agency last month.

Thank you for standing by. At this time, I would like to welcome everyone to the Co-Diagnostics, Inc. Second Quarter 2026 Earnings Webcast. [Operator Instructions] I would now like to turn the ...

Qiagen also completed a $500 million share repurchase in January and raised its annual dividend 40% to $0.35 per share. The ...

The authentication of phototrophs and their derived products has become critical for food security, consumer safety, ...

Qiagen (NYSE:QGEN) reported second-quarter 2026 results above its prior outlook, with net sales of $535 million, unchanged ...

Bryan Kohberger appears at the Ada County Courthouse for his sentencing hearing on July 23, 2025 in Boise, Idaho. Kyle Green-Pool/Getty Images Nearly four years after the November 2022 murders of four ...

LabPMM ®, an Invivoscribe ® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is ...

Countable Labs’ lead product, Countable PCR, is designed for application in areas including minimal residual disease (MRD) testing, cell and gene therapy (CGT), and biomarker validation. Credit: ...

NEW YORK – Startup Signal Bioscience is aiming to drive higher digital PCR and real-time PCR multiplexing at a lower cost using proprietary technology that separates amplification from signal ...

“Detecting rare genetic events with confidence is still a major challenge for many PCR workflows. Traditional methods often fall short when sensitivity and accuracy matter most. This eBook shows how ...